112 related articles for article (PubMed ID: 16030124)
41. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China.
Dong Z; Guo W; Zhou R; Wan L; Li Y; Wang N; Kuang G; Wang S
J Clin Gastroenterol; 2008 Sep; 42(8):910-5. PubMed ID: 18645534
[TBL] [Abstract][Full Text] [Related]
43. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
[TBL] [Abstract][Full Text] [Related]
44. [XPD (ERCC2) (Xeroderma pigmentosum, group D). Reparation gene].
Bull Cancer; 1998 Dec; 85(12):987-8. PubMed ID: 9988553
[No Abstract] [Full Text] [Related]
45. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
46. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
[TBL] [Abstract][Full Text] [Related]
47. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer.
Bu D; Tomlinson G; Lewis CM; Zhang C; Kildebeck E; Euhus DM
Breast Cancer Res Treat; 2006 Oct; 99(3):257-65. PubMed ID: 16596326
[TBL] [Abstract][Full Text] [Related]
48. Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population.
Butkiewicz D; Rusin M; Harris CC; Chorazy M
Hum Mutat; 2000 Jun; 15(6):577-8. PubMed ID: 10862089
[TBL] [Abstract][Full Text] [Related]
49. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
[TBL] [Abstract][Full Text] [Related]
50. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
Dianzani I; Gibello L; Biava A; Giordano M; Bertolotti M; Betti M; Ferrante D; Guarrera S; Betta GP; Mirabelli D; Matullo G; Magnani C
Mutat Res; 2006 Jul; 599(1-2):124-34. PubMed ID: 16564556
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer.
Raaschou-Nielsen O; Sørensen M; Overvad K; Tjønneland A; Vogel U
Lung Cancer; 2008 Feb; 59(2):171-9. PubMed ID: 17913280
[TBL] [Abstract][Full Text] [Related]
52. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
53. Vitamin D receptor variants and breast cancer risk in the Polish population.
Gapska P; Scott RJ; Serrano-Fernandez P; Huzarski T; Byrski T; Kładny J; Gronwald J; Górski B; Cybulski C; Lubinski J; Debniak T
Breast Cancer Res Treat; 2009 Jun; 115(3):629-33. PubMed ID: 18587672
[TBL] [Abstract][Full Text] [Related]
54. Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression.
Wolfe KJ; Wickliffe JK; Hill CE; Paolini M; Ammenheuser MM; Abdel-Rahman SZ
Pharmacogenet Genomics; 2007 Nov; 17(11):897-905. PubMed ID: 18075460
[TBL] [Abstract][Full Text] [Related]
55. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
[TBL] [Abstract][Full Text] [Related]
56. Short PNA molecular beacons for real-time PCR allelic discrimination of single nucleotide polymorphisms.
Petersen K; Vogel U; Rockenbauer E; Nielsen KV; Kølvraa S; Bolund L; Nexø B
Mol Cell Probes; 2004 Apr; 18(2):117-22. PubMed ID: 15051121
[TBL] [Abstract][Full Text] [Related]
57. Role of ERCC2 and ERCC3 gene polymorphisms in the development of osteosarcoma.
Ma X; Zhang Y; Sun TS; Yao JH
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051024
[TBL] [Abstract][Full Text] [Related]
58. Enhancing alkylating agent resistance through ERCC2 gene transfection in human glioma cell line.
Chen Z; Zhang J; Mohr G
Chin Med J (Engl); 2003 Aug; 116(8):1171-4. PubMed ID: 12935404
[TBL] [Abstract][Full Text] [Related]
59. Re: M. D. Dabholkar et al., Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261-1266, 1995.
Panasci L; McQuillan A; Malapetsa A; Christodoulopoulos GR
Cancer Res; 1995 Sep; 55(17):3933-4. PubMed ID: 7641213
[No Abstract] [Full Text] [Related]
60. Interethnic variability of ERCC2 polymorphisms.
King CR; Yu J; Freimuth RR; McLeod HL; Marsh S
Pharmacogenomics J; 2005; 5(1):54-9. PubMed ID: 15534626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
